06:51 PM, 4th Nov 2025
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results alongwith the Limited Review Report as on September 30 2025.